Full Press Release Details
The Oncology Institute Announces
Changes to Board of Directors
Richard Barasch to Retire; Anne McGeorge Brings Extensive
Financial Experience to Role as New Chairman
CERRITOS, Calif., August 13, 2025 (GLOBE NEWSWIRE) -- The Oncology
Institute, Inc. ("TOI") (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced
that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves
as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role.
"We are thrilled to have Anne McGeorge serve as our next
Chairman of the Board," said Daniel Virnich, MD, CEO of The Oncology Institute. "Having worked with Anne since she joined
The Oncology Institute's board in 2021, I feel confident that she is the right person for the job. Her extensive experience in providing
strategic guidance to management teams, deep knowledge of the healthcare space and proven financial acumen have been greatly beneficial
to The Oncology Institute thus far and we look forward to working even more closely with her as she takes on this leadership role."
Ms. McGeorge brings over 35 years of experience as a trusted
operational and financial advisor to healthcare organizations. Before retiring in 2017, she helped launch Grant Thornton LLP's Global
Health Care and Life Sciences Practice and served as the managing partner for 10 years, growing it into a $250 million global business
during her time in the position. Earlier in her career, she was a partner at both Deloitte and Arthur Andersen and an adjunct professor
at the University of North Carolina School of Public Health. Currently, Ms. McGeorge serves on the board of directors and as the chair
of the Audit Committee of Dianthus Therapeutics (NASDAQ: DNTH), a clinical-stage biotechnology company, Nimbus Therapeutics and CitiusTech,
both privately held healthcare companies, CLEAR Insurance, a Cayman based Captive Insurance Company, and the William and Mary Business
School Foundation. She holds an MS degree in Accounting from the University of Virginia and a BBA degree in Accounting from William &
"I am honored to serve as Chairman and look forward to
working with the board and management team to continue advancing our mission of providing exceptional oncology care," said Ms. McGeorge.
Dr. Virnich added, "We thank Richard for his outstanding
leadership and dedication to The Oncology Institute. Under his guidance, we became a publicly traded company, strengthened our management
team, and we were able to prove our business model and value to payors outside of California. The leadership that he brought to our Board
and the organization as a whole will have a lasting impact."
Mr. Richard Barasch said, ""Having been with The
Oncology Institute since it became a public company, I have had the privilege of getting to know this impressive mission-driven organization,
so capably led by CEO Dan Virnich. Anne McGeorge is the best candidate to take over my role as Chairman, and I look forward to seeing
the contributions she will surely make with her impressive experience and skillset."
About The Oncology Institute
Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing
oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer
care to a population of approximately 1.9 million patients including clinical trials, transfusions, and other care delivery models traditionally
associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and
affiliate locations of care across five states and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
The Oncology Institute, Inc.